Caplin Point Laboratories (NSE:CAPLIPOINT) E10: ₹48.22 (As of Mar. 2026)


NSE:CAPLIPOINT Caplin Point Laboratories Ltd NSE:CAPLIPOINT
92 GF Score
Price ₹2,506.40
GF Value ₹2,073.29
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Caplin Point Laboratories E10?

Caplin Point Laboratories NSE:CAPLIPOINT -0.50% 92 E10 is ₹48.22 as of Mar. 2026. GuruFocus rates NSE:CAPLIPOINT with a GF Score™ of 92/100 and a GF Value™ of ₹2,073.29 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Caplin Point Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹22.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹48.22 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Caplin Point Laboratories's average E10 Growth Rate was 23.50% per year. During the past 3 years, the average E10 Growth Rate was 24.10% per year. During the past 5 years, the average E10 Growth Rate was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Caplin Point Laboratories was 28.10% per year. The lowest was 24.10% per year. And the median was 26.20% per year.

As of today (2026-06-28), Caplin Point Laboratories's current stock price is ₹2506.40. Caplin Point Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹48.22. Caplin Point Laboratories's Shiller PE Ratio of today is 51.98.

During the past 13 years, the highest Shiller PE Ratio of Caplin Point Laboratories was 72.36. The lowest was 23.67. And the median was 40.77.


Caplin Point Laboratories  (NSE:CAPLIPOINT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Caplin Point Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2506.40/48.22
=51.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Caplin Point Laboratories was 72.36. The lowest was 23.67. And the median was 40.77.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Caplin Point Laboratories E10 Related Terms


Caplin Point Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Caplin Point Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caplin Point Laboratories E10 Chart

Caplin Point Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.39 25.18 31.81 39.01 48.22

Caplin Point Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.01 41.36 43.91 45.96 48.22

NSE:CAPLIPOINT vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Shiller PE Ratio falls into.


NSE:CAPLIPOINT
92GF Score
Caplin Point Laboratories Ltd NSE:CAPLIPOINT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caplin Point Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Caplin Point Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=22.31/164.2724*164.2724
=22.310

Current CPI (Mar. 2026) = 164.2724.

Caplin Point Laboratories Quarterly Data

per share eps CPI Adj_EPS
201606 2.136 105.961 3.311
201609 0.598 105.961 0.927
201612 3.150 105.196 4.919
201703 4.410 105.196 6.887
201706 4.790 107.109 7.346
201709 4.690 109.021 7.067
201712 4.940 109.404 7.418
201803 4.740 109.786 7.092
201806 4.920 111.317 7.261
201809 6.180 115.142 8.817
201812 6.030 115.142 8.603
201903 6.550 118.202 9.103
201906 6.460 120.880 8.779
201909 7.510 123.175 10.016
201912 7.680 126.235 9.994
202003 6.410 124.705 8.444
202006 7.150 127.000 9.248
202009 7.460 130.118 9.418
202012 8.460 130.889 10.618
202103 8.640 131.771 10.771
202106 9.250 134.084 11.333
202109 9.860 135.847 11.923
202112 9.810 138.161 11.664
202203 10.340 138.822 12.236
202206 11.120 142.347 12.833
202209 11.990 144.661 13.615
202212 12.845 145.763 14.476
202303 13.453 146.865 15.048
202306 13.550 150.280 14.812
202309 15.060 151.492 16.331
202312 15.390 152.924 16.532
202403 15.900 153.035 17.068
202406 16.240 155.789 17.124
202409 17.120 157.882 17.813
202412 18.190 158.323 18.874
202503 18.690 157.552 19.487
202506 20.030 159.755 20.596
202509 20.250 162.289 20.497
202512 21.510 163.281 21.641
202603 22.310 164.272 22.310

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹48.22 mean?
Caplin Point Laboratories (NSE:CAPLIPOINT) has a E10 of ₹48.22 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Caplin Point Laboratories and its competitors.
Is Caplin Point Laboratories' E10 too high?
Caplin Point Laboratories' current E10 is ₹48.22. Overall, Caplin Point Laboratories has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Caplin Point Laboratories' E10 compare to ZTS?
Caplin Point Laboratories' E10 of ₹48.22 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Caplin Point Laboratories and its competitors. Caplin Point Laboratories's current E10 is ₹48.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caplin Point Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Caplin Point Laboratories (NSE:CAPLIPOINT) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,073.29, compared to a current price of ₹2,506.40 — trading 20.9% above its estimated fair value. The current E10 is ₹48.22. Caplin Point Laboratories' overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Caplin Point Laboratories (NSE:CAPLIPOINT), the current E10 is ₹48.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Caplin Point Laboratories (NSE:CAPLIPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Caplin Point Laboratories stock appears to be overvalued. The current stock price of ₹2,506.40 is trading 20.9% above its estimated GF Value™ of ₹2,073.29. GuruFocus considers Caplin Point Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:CAPLIPOINT:

  • E10: ₹48.22
  • GF Value™: ₹2,073.29 vs. price of ₹2,506.40 (20.9% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAPLIPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Caplin Point Laboratories Business Description

Other Exchanges 524742:India
Address Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
92GF Score

Get the complete analysis for NSE:CAPLIPOINT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,506.40
Price
₹2,073.29
GF Value